THE VALUE OF 2 MV. ROENTGEN-RAY THERAPY IN DIFFERENTIATED THYROID CARCINOMA
- 1 February 1967
- journal article
- research article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 99 (2) , 352-364
- https://doi.org/10.2214/ajr.99.2.352
Abstract
Papillary and follicular carcinoma of the thyroid is radiosensitive. The survival rate of 82% for 5 years is surgically nonresectable cases using external radiation as the prime modality is equal to our results with radical surgery plus megavolt external radiation. The high 5 year survival rate in the limited number of cases in Stage I and Stage II suggests that radical surgery is not necessary. The addition of external radiation should be reserved for cases in which surgery has not eradicated the known disease or in lieu of radical neck dissection when residual disease is known or suspected. Our experience continues to show that better results are obtained with supervoltage than with orthovoltage radiation, primarily because we are able to deliver twice the dosage with fewer local reactions.This publication has 0 references indexed in Scilit: